Clinical Performance of the Alinity m HR HPV Assay in a Large Urban Cervical Cancer Screening Program in the United States
Background: Certain high-risk human papillomavirus (HR HPV) genotypes may carry greater risk of progression to high-grade cervical cancer, and extended HR HPV genotyping may help refine risk assessment. Objectives: To examine the performance of the Alinity m HR HPV assay in comparison to cobas 4800 HPV assay (cobas 4800) and the association between cytology results, age, and extended HR HPV genotyping.
Authors
- Joshua Kostera (ORCID: https://orcid.org/0009-0002-8679-1677)
Publication Details
- Journal
- Journal of Gynecology and Womens Health
- Published
- 2025-03-19
- DOI
- https://doi.org/10.19080/jgwh.2025.27.556211
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00